Share, Send, or Save
Depression resources

he following are depression resources that we hope you find useful to help further educate yourself and your family and friends about this common and treatable disease.

The Web sites below are neither owned nor controlled by Pfizer. Pfizer is not responsible for the content or services of these sites.

  • American Psychiatric Foundation Committed to operating programs and funding initiatives that promote awareness of mental illnesses, the effectiveness of treatment, and the importance of early intervention.
  • Depression and Bipolar Support Alliance A patient-directed organization with a purpose of educating patients, families, and the public about the nature of depressive illness.
Depression resources
  • HealthyMinds.org Created by the American Psychiatric Association, the site provides information on psychiatric disorders such as depression and provides help locating a psychiatrist in your local area.
  • National Alliance on Mental Illness A support, educational, and advocacy organization for people with mental illness and their families, with over 1200 local affiliates; local affiliates give guidance to finding treatment.
  • National Institute of Mental Health The largest scientific organization in the world dedicated to research focused on the understanding, treatment, and prevention of mental disorders and the promotion of mental health.
Depression resources
  • Mental Health America
    (formally, the National Mental Health Association) An association that works with over 340 affiliates to promote mental health through advocacy, education, research, and services.
  • Depression Connect

    An online community where you can ask questions, share experiences and learn from other people whose lives are also touched by depression.

PRISTIQ® (desvenlafaxine) is a prescription medication approved for the treatment of major depressive disorder in adults. PRISTIQ is not indicated for the treatment of any other mental illness, including bipolar disorder or depressive episodes of bipolar disorder.

What Would You Like to Do Next?
Important Safety Information About PRISTIQ
Suicidality and Antidepressant Drugs Antidepressants increased the risk of suicidal thinking and behavior in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy or when the dose is changed should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior such as becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Should these occur, report them to a doctor right away. PRISTIQ is not approved for use in children under 18.

Do not take PRISTIQ if you are allergic to desvenlafaxine, venlafaxine, or any of the ingredients in PRISTIQ. Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid).

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

 
 
Copyright © 2013 Pfizer Inc. All rights reserved. PQP533710-01